Breast Cancer News

Two blood-based biomarkers may help identify patients with cancer who are more likely to experience gastrointestinal symptoms during chemotherapy.

Limiting eligibility criteria, recruiting trusted community messengers and reducing financial burdens can help improve diversity of clinical trial enrollees, a panel of professionals said during a Friends of Cancer Research webinar.

Momentous strides have been made in the understanding of disease biology for many cancer types.

Certain natural compounds derived from soy and other plants can significantly reduce the risk for breast cancer recurrence or death, data published in JNCI Cancer Spectrum suggest.

Among patients with rheumatoid arthritis diagnosed with breast cancer, the utilization of TNF inhibitors and other biologic disease-modifying antirheumatic drugs has not risen for more than a decade, according to data published in Arthritis Care & Research.

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

Researchers have harnessed the ability of some molecules to vibrate strongly when stimulated by light, potentially laying the groundwork for a new approach to destroying cancer cells.

Taxane-based chemotherapy appeared safe and effective during pregnancy for young women with breast cancer, according to study results.

SAN ANTONIO — Women with breast cancer who harbored a BRCA1 mutation and developed contralateral breast cancer had a mortality risk double that of women who did not develop contralateral breast cancer, according to study results.

From 2000-2019, breast cancer incidence rates increased among women aged 20 to 49 years, with more elevated rates among non-Hispanic Black women aged 20 to 29 and 30 to 39 years, according to study findings published in JAMA Network Open.